Studies suggest that GIP may enhance the tolerability of GLP-1 therapies, particularly by reducing gastrointestinal side effects
Expression of organic cation transporter SLC22A16 in human epithelial ovarian cancer: a possible role of the adriamycin importer
Primary antibodies targeted FOXO4, Leydig cell markers (StAR, CYP11A1, 3-HSD), spermatogenesis markers (PCNA, PLZF, UCHL1, SCP3), and senescence/apoptosis markers (Ser15-phospho-p53)
Gerstel MS, Place VA
When you stop taking a GLP-1, your blood sugar and hunger levels often return to where they were before
It exists in every cell of the body and is uniquely capable of donating electrons to neutralize unstable free radicals without becoming dangerously reactive itself